Howard Edington
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
Papers in
- Oncology 20
- CAR-T cell therapy research 7
- Cutaneous Melanoma Detection and Management 6
- Cytokine Signaling Pathways and Interactions 5
- Cancer Immunotherapy and Biomarkers 4
- Immunology 16
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 4
- Co-authors
- John M. Kirkwood (24 shared papers)Hideaki Tahara (2 shared papers)Timothy R. Billiar (2 shared papers)Uma N. M. Rao (9 shared papers)Walter J. Storkus (2 shared papers)Robert D. Schreiber (1 shared paper)Chet Nastala (1 shared paper)Michael J. Brunda (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Clinical Cancer Research (3 papers)Journal of Neuro-Oncology (2 papers)Human Gene Therapy (2 papers)Molecular Imaging (2 papers)
- Partner nations
- United StatesHungaryNetherlands
In The Last Decade
Howard Edington
50 papers receiving 3.4k citations
Howard Edington's Hit Papers
Peers
Comparison fields: 5 of 110
- Immunology 1.5k
- Oncology 1.5k
- Rehabilitation 230
- Otorhinolaryngology 68
- Genetics 128
Countries citing papers authored by Howard Edington
This map shows the geographic impact of Howard Edington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Edington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Edington more than expected).
Fields of papers citing papers by Howard Edington
This network shows the impact of papers produced by Howard Edington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Edington. The network helps show where Howard Edington may publish in the future.
Co-authors
The 25 scholars most cited alongside Howard Edington, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recombinant IL-12 administration induces tumor regression in association with IFN- gamma production. Hit paper breakdown → | 1994 | 672 |
| 2 | Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. | 1997 | 460 |
| 3 | 1998 | 356 | |
| 4 | 1999 | 311 | |
| 5 | 2014 | 233 | |
| 6 | 2006 | 192 | |
| 7 | 2007 | 168 | |
| 8 | 2007 | 100 | |
| 9 | 2007 | 88 | |
| 10 | 1998 | 84 | |
| 11 | 2007 | 70 | |
| 12 | 2006 | 64 | |
| 13 | 2003 | 57 | |
| 14 | 2000 | 52 | |
| 15 | 2001 | 51 | |
| 16 | 2006 | 50 | |
| 17 | 2011 | 44 | |
| 18 | Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions. | 1999 | 40 |
| 19 | 1999 | 38 | |
| 20 | 2000 | 33 |
About Howard Edington
Howard Edington is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Cancer Research, having authored 53 papers that have together received 3.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), CAR-T cell therapy research (7 papers), Cutaneous Melanoma Detection and Management (6 papers), Virus-based gene therapy research (6 papers), Melanoma and MAPK Pathways (5 papers), Cytokine Signaling Pathways and Interactions (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Immunology (1.5k citations), Oncology (1.5k citations), Rehabilitation (230 citations), Otorhinolaryngology (68 citations) and Genetics (128 citations). Howard Edington has collaborated with scholars based in United States, Hungary and Netherlands. Frequent co-authors include John M. Kirkwood, Hideaki Tahara, Timothy R. Billiar, Uma N. M. Rao, Walter J. Storkus, Robert D. Schreiber, Chet Nastala, Michael J. Brunda, Maurice K. Gately and S F Wolf. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Neuro-Oncology, Human Gene Therapy and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.